Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWitan Regulatory News (WTAN)

Share Price Information for Witan (WTAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 263.50
Bid: 263.00
Ask: 264.00
Change: 0.50 (0.19%)
Spread: 1.00 (0.38%)
Open: 264.50
High: 264.50
Low: 262.50
Prev. Close: 263.00
WTAN Live PriceLast checked at -
Witan is an Investment Trust

To achieve an investment total return exceeding that of the benchmark of the Company over the longer term, together with growth in the dividend ahead of inflation through active investment in global equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviewed Witan Pacific Investment Trust

16 Dec 2019 15:46

RNS Number : 0400X
Witan Investment Trust PLC
16 December 2019
 

 

London, UK, 16 December 2019

Edison issues review on Witan Pacific Investment Trust (WPC)

Witan Pacific Investment Trust (WPC) offers broad exposure to the Asia Pacific region (including Japan), employing a multi-manager strategy. The board remains confident that the current line-up of four complementary managers is capable of good long-term outperformance; however, it has a contingency measure in place. If WPC does not outperform its benchmark in the two years ending 31 January 2021, investors will be given the opportunity to realise their holdings close to NAV, so either relative performance will improve or the trust's discount will narrow. WPC has a progressive dividend policy; its annual distribution has increased for the last 14 consecutive years and the trust currently offers a 2.1% yield.

 

WPC's discount has continued to narrow following the board's February 2019 announcement to address the trust's investment performance. Its shares are currently trading at a 9.1% discount to cum-income NAV, which is significantly lower than the 11.3%, 13.0%, 13.1% and 14.1% average discounts over the last one, three, five and 10 years respectively. The board actively repurchases shares when they are trading at a substantial and anomalous discount to NAV.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at Edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFFDFIMFUSELE
Date   Source Headline
2nd Feb 20245:26 pmRNSTransaction in Own Shares
2nd Feb 202412:58 pmRNSNet Asset Value(s)
1st Feb 20245:09 pmRNSTransaction in Own Shares
1st Feb 202412:30 pmRNSNet Asset Value(s)
1st Feb 20248:56 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSShare buyback authority
31st Jan 20245:03 pmRNSTransaction in Own Shares
31st Jan 202412:51 pmRNSNet Asset Value(s)
30th Jan 20245:09 pmRNSTransaction in Own Shares
30th Jan 202412:41 pmRNSNet Asset Value(s)
29th Jan 20245:25 pmRNSTransaction in Own Shares
29th Jan 202411:49 amRNSNet Asset Value(s)
26th Jan 20245:03 pmRNSTransaction in Own Shares
26th Jan 202412:45 pmRNSNet Asset Value(s)
25th Jan 20245:18 pmRNSTransaction in Own Shares
25th Jan 202412:09 pmRNSNet Asset Value(s)
24th Jan 20245:07 pmRNSTransaction in Own Shares
24th Jan 202411:27 amRNSNet Asset Value(s)
23rd Jan 20245:05 pmRNSTransaction in Own Shares
23rd Jan 202412:23 pmRNSNet Asset Value(s)
22nd Jan 20245:02 pmRNSTransaction in Own Shares
22nd Jan 202412:15 pmRNSNet Asset Value(s)
22nd Jan 20247:00 amRNSBlock listing Interim Review
19th Jan 20245:11 pmRNSTransaction in Own Shares
19th Jan 20243:34 pmRNSPortfolio Listing as at 31 December 2023
19th Jan 20241:15 pmRNSNet Asset Value(s)
18th Jan 20245:25 pmRNSTransaction in Own Shares
18th Jan 202412:34 pmRNSNet Asset Value(s)
17th Jan 20245:03 pmRNSTransaction in Own Shares
17th Jan 20242:07 pmRNSNet Asset Value(s)
16th Jan 20245:01 pmRNSTransaction in Own Shares
16th Jan 20244:06 pmRNSMonthly Factsheet as at 31 December 2023
16th Jan 202412:44 pmRNSNet Asset Value(s)
16th Jan 202410:42 amRNSDirector/PDMR Shareholding
15th Jan 20245:06 pmRNSTransaction in Own Shares
15th Jan 202412:51 pmRNSNet Asset Value(s)
12th Jan 20245:09 pmRNSTransaction in Own Shares
12th Jan 202412:00 pmRNSNet Asset Value(s)
11th Jan 20245:22 pmRNSTransaction in Own Shares
11th Jan 202412:48 pmRNSNet Asset Value(s)
10th Jan 20245:36 pmRNSTransaction in Own Shares
10th Jan 20241:09 pmRNSNet Asset Value(s)
9th Jan 20245:24 pmRNSTransaction in Own Shares
9th Jan 20241:52 pmRNSNet Asset Value(s)
8th Jan 20245:16 pmRNSTransaction in Own Shares
8th Jan 20242:20 pmRNSNet Asset Value(s)
5th Jan 20245:02 pmRNSTransaction in Own Shares
5th Jan 202412:56 pmRNSNet Asset Value(s)
4th Jan 20245:11 pmRNSTransaction in Own Shares
4th Jan 202411:58 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.